Study on adjuvant therapy of adenomyosis with Xueping Tablet: a randomized controlled trial.
Not Applicable
Recruiting
- Conditions
- Adenomyosis
- Registration Number
- ITMCTR2100004364
- Lead Sponsor
- Shanghai Changhai Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- Not specified
Inclusion Criteria
1. Women who meet the diagnostic criteria for adenomyosis, aged 28-48 years old, are non-menopausal and non-lactating;
2. Those who voluntarily participate in this experiment and sign the informed consent.
Exclusion Criteria
1. Gnrh-a and steroid hormone use history within 3 months;
2, levonorgestrel or iUD placement contraindications;
3. Patients with cardiovascular and cerebrovascular diseases, liver, kidney, diabetes, tumor and other serious diseases;
4. Mental illness patients and long-term drinking or taking drugs affect cognition;
5. Patients with coagulation dysfunction or previous thrombotic diseases;
6. Participating in other drug clinical subjects;
7. Had a history of allergy to Traditional Chinese medicine.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The degree of dysmenorrhea;
- Secondary Outcome Measures
Name Time Method Rate of surgery;